Page 146 - 71_02

MANUEL DOMÍNGUEZ CARMONA AN. R. ACAD. NAC. FARM.

(94) PATER, J. B.; LEE, J. P. (1992): The value of high quality Electromyographic
(95) monitoring for botulinum toxin therapy. ESA.
RICHTER, J. E. (1995): Motility disorders of the esophagus. En: Yamada T,
(96) Alpers DH, Owyang C, Powel DW, Silverstein FES. Eds. Textbook of Gas-
(97) troenterology. Vol. 1 (2.a ed.): Philadelphia, JB Lippencott Comp. 1174-1213.
REYNOLDS, J. C.; PARKMAN, H. P. (1989): Achalasia. Gastroenterol Clin North
(98) Am 18: 223-255.
(99) RICHARDS, W. O.; CLEMENTS, R. H.; WANG, P. C.; LIND, C. D.; MERTZ, H.; LADIPO,
(100) J. K.; HOLZMAN, M. D.; SHARP, K. W. (1999): Prevalence of gastroesophageal
(101) reflux after laparoscopic Heller myotomy. Surg Endosc 13: 1010-1014.
RODRÍGUEZ, J. M.; GÓMEZ DE LIAÑO, P.; GÓMEZ DE LIAÑO, R. (1992): Tratamien-
(102) to del estrabismo con toxina botulínica. Acta Estrabológica 1992; 21-27.
(103) ROSSY, L. A.; BUCKELEW, S. P.; DORR, N. Y COLS. (1999): A meta-analysis of
fibromyalgia treatment interventions. Ann Behav Med 21: 180-191.
(104) SANDERSON, D. R.; ELLIS, F. H.; OLSEN, A. M. (1970): Achalasia ofthe esopha-
gus: Re-sults of therapy by dilatation. 1950-1967. Chest. 58: 116-21.
(105) SANDLER, R. S.; NYREN, O.; EKBOM, A. Y COL. (1996): The risk of esophageal
cancer in patients with achalasia: A population-based study. JAMA 274:
(106) 359-362.
SCHANTZ, E. J.; JOHNSON, E. A. (1992): Properties and use of botulinum toxin
(107) and other microbial neurotoxins in Medicine. Microbiol Rev 56: 80-99.
(108) SCHIAVO, G.; BENFENATI, F.; POULAIN, B. Y COL. (1992): Tetanus Y botulinum-
B neurotoxins block neurotransmitter release by proteolytic cleavage of
(109) synaptobrevin. Nature. 359: 832-835.
(110) SCOTT, A. B. (1980): Botulinum toxin injection into extraocular muscles as
an alternative to strabismus surgery. J Pediatric Ophthalmol Strabismus 17:
21-25.
SCOTT, A. B. (1989): Botulinum toxin treatment of strabismus. Focal points.
Clinical Modules for Ophthalmologists. San Francisco, American Academy
of Ophthalmology. 7: 1-11.
SCOTT, A. B.; MAGOON, E. H.; MCNEER, K. W. Y COL. (1997): Botulinum toxin
of chilhood strabismus. Ophthalmology 1990; 97: 1435-1438; SHOENUT, F.;
DUERKSEN, D., YAFFE, C. S. (1990): A prospective assesement of gastrroeso-
phageal reflux. Am J Gastroenterol 92: 1109-1112.
SHIINO, Y.; FILIPI, C. J.; AWARD, Z. T.; TOMONAGA, T.; MARSH, R. E. (1999):
Surgery for achalasia. J GastroÍntest Surg 3: 447-455.
SHIMA, F.; FUKUI, M.; KITAMURA, K.; KUROMATSU, C.; OKAMURA, T. (1988): Diag-
nosis and surgical treatment of spasmodic torticollis of the nerve origin.
Neurosurgery 22: 358-363.
SILBERSTEIN, S. Y COLS. (2000): Botulinum toxin type as a migrain preventive
treatment 40: 445-450.
SIMPSON, L. L. (1989): Peripheral accións of the botulinum toxins. En Simp-
son LL, ed. Botulinum Neurotoxin and Tetanus Toxin. New York, NY: Aca-
demic Press Inc 153-178.

426